{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:39:50Z","timestamp":1793907590957,"version":"4.8.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000155","name":"Government of Canada Social Sciences and Humanities Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Social Science & Medicine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.socscimed.2025.118247","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T11:54:13Z","timestamp":1748260453000},"page":"118247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Framing coalitions and the Canadian overdose crisis: The case of opioid marketing"],"prefix":"10.1016","volume":"381","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9451-9668","authenticated-orcid":false,"given":"Daniel","family":"Eisenkraft Klein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7640-8614","authenticated-orcid":false,"given":"Quinn","family":"Grundy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7027-8046","authenticated-orcid":false,"given":"Benjamin","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7838-0769","authenticated-orcid":false,"given":"Robert","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.socscimed.2025.118247_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11013-009-9129-3","article-title":"Getting to yes: corporate power and the creation of a psychopharmaceutical blockbuster","volume":"33","author":"Applbaum","year":"2009","journal-title":"Cult. Med. Psychiatr."},{"issue":"2","key":"10.1016\/j.socscimed.2025.118247_bib2","doi-asserted-by":"crossref","DOI":"10.1177\/2158244016653986","article-title":"Problematizations in health policy: questioning how \u201cproblems\u201d are constituted in policies","volume":"6","author":"Bacchi","year":"2016","journal-title":"Sage Open"},{"issue":"6","key":"10.1016\/j.socscimed.2025.118247_bib3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.24095\/hpcdp.38.6.02","article-title":"Evidence synthesis - the opioid crisis in Canada: a national perspective","volume":"38","author":"Belzak","year":"2018","journal-title":"Health Promot. Chronic Dis. Prev. Canada"},{"issue":"12","key":"10.1016\/j.socscimed.2025.118247_bib4","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1080\/10410236.2022.2093555","article-title":"Framing and policymaker evaluations of the opioid crisis","volume":"38","author":"Bergan","year":"2023","journal-title":"Health Commun."},{"key":"10.1016\/j.socscimed.2025.118247_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","article-title":"The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis","volume":"71","author":"Ciccarone","year":"2019","journal-title":"Int. J. Drug Pol."},{"issue":"4","key":"10.1016\/j.socscimed.2025.118247_bib6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Curr. Opin. Psychiatr."},{"key":"10.1016\/j.socscimed.2025.118247_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102976","article-title":"Consumer protection in drug policy: the human rights case for safe supply as an element of harm reduction","volume":"91","author":"Csete","year":"2021","journal-title":"Int. J. Drug Pol."},{"key":"10.1016\/j.socscimed.2025.118247_bib53","series-title":"Policy Framing Analysis. Policy Framing in the European","first-page":"26","author":"Daviter","year":"2011"},{"key":"10.1016\/j.socscimed.2025.118247_bib8","article-title":"How the identity of substance users shapes public opinion on opioid policy","author":"de Benedictis-Kessner","year":"2022","journal-title":"Polit. Behav."},{"issue":"6","key":"10.1016\/j.socscimed.2025.118247_bib9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.amjmed.2017.12.045","article-title":"Backstories on the US opioid epidemic. Good intentions gone bad, an industry gone rogue, and watch dogs gone to sleep","volume":"131","author":"deShazo","year":"2018","journal-title":"Am. J. Med."},{"issue":"6","key":"10.1016\/j.socscimed.2025.118247_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0287861","article-title":"Pharmaceutical company responses to Canadian opioid advertising restrictions: a framing analysis","volume":"18","author":"Eisenkraft Klein","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.socscimed.2025.118247_bib11","doi-asserted-by":"crossref","DOI":"10.18192\/cjmsrcem.v18i1.6497","article-title":"\u201cWe support harm reduction\u201d: frame analysis of Canadian news media coverage of the opioid crisis","volume":"18","author":"Ferguson","year":"2022","journal-title":"Can. J. Media Stud."},{"issue":"6","key":"10.1016\/j.socscimed.2025.118247_bib12","first-page":"465","article-title":"Opioid prescribing is a surrogate for inadequate pain management resources","volume":"62","author":"Finestone","year":"2016","journal-title":"Can. Fam. Physician"},{"issue":"17\u201318","key":"10.1016\/j.socscimed.2025.118247_bib13","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1503\/cmaj.160356","article-title":"Effective Canadian policy to reduce harms from prescription opioids: learning from past failures","volume":"188","author":"Fischer","year":"2016","journal-title":"CMAJ"},{"key":"10.1016\/j.socscimed.2025.118247_bib14","series-title":"Reframing Public Policy: Discursive Politics and Deliberative Practices","article-title":"Discourse versus advocacy coalitions: interpreting policy change and learning","author":"Fischer","year":"2003"},{"key":"10.1016\/j.socscimed.2025.118247_bib15","article-title":"Pharmaceutical industry use of key opinion leaders to market prescription opioids: a review of internal industry documents","volume":"16","author":"Gac","year":"2024","journal-title":"Explor. Res. Clin. Soc. Pharm."},{"key":"10.1016\/j.socscimed.2025.118247_bib54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0741088320944918","article-title":"The Opioid Epidemic and the Pursuit of Moral Medicine: A Computational-Rhetorical Analysis","volume":"38","author":"Graham","year":"2021","journal-title":"Written Communication"},{"issue":"1","key":"10.1016\/j.socscimed.2025.118247_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.6007","article-title":"Association of pharmaceutical industry marketing of opioid products with mortality from opioid-related overdoses","volume":"2","author":"Hadland","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.socscimed.2025.118247_bib49","series-title":"Discourse Coalitions and the Institutionalization of Practice","first-page":"43","author":"Hajer","year":"1993"},{"key":"10.1016\/j.socscimed.2025.118247_bib17","series-title":"The Opioid Crisis in Canada [7]","author":"Hatt","year":"2021"},{"key":"10.1016\/j.socscimed.2025.118247_bib50","unstructured":"Health Canada, 2021. Safer supply: Prescribed medications as a safer alternative to toxic illegal drugs. URL https:\/\/www.canada.ca\/en\/health-canada\/services\/opioids\/responding-canada-opioid-crisis\/safer-supply.html (accessed 5.26.25)."},{"key":"10.1016\/j.socscimed.2025.118247_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102769","article-title":"Tackling the overdose crisis: the role of safe supply","volume":"80","author":"Ivsins","year":"2020","journal-title":"Int. J. Drug Pol."},{"key":"10.1016\/j.socscimed.2025.118247_bib51","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1017\/S0143814X00007431","article-title":"Evaluating the Advocacy Coalition Framework","volume":"14","author":"Jenkins-Smith","year":"1994","journal-title":"Journal of Public Policy"},{"key":"10.1016\/j.socscimed.2025.118247_bib24","series-title":"Empire of Pain: the Secret History of the Sackler Dynasty. Bond Street Books","author":"Keefe","year":"2021"},{"issue":"3","key":"10.1016\/j.socscimed.2025.118247_bib25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.46747\/cfp.6903192","article-title":"Systematic assessment of opioid advertisements in general medical journals","volume":"69","author":"Kirubarajan","year":"2023","journal-title":"Can. Fam. Physician"},{"issue":"6","key":"10.1016\/j.socscimed.2025.118247_bib26","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/heapol\/czv128","article-title":"Framing and the health policy process: a scoping review","volume":"31","author":"Koon","year":"2016","journal-title":"Health Pol. Plann."},{"issue":"4","key":"10.1016\/j.socscimed.2025.118247_bib27","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1177\/27551938231165158","article-title":"Complaints about violations of voluntary and pharmaceutical industry-run medicine promotion codes in Canada","volume":"53","author":"Lexchin","year":"2023","journal-title":"Int. J. Soc. Determ. Health Health Services"},{"issue":"2","key":"10.1016\/j.socscimed.2025.118247_bib28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.20529\/IJME.2024.006","article-title":"Opioid promotion in Canada: a narrative review","volume":"9","author":"Lexchin","year":"2024","journal-title":"Indian J. Med. Ethics"},{"key":"10.1016\/j.socscimed.2025.118247_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.103997","article-title":"The opioid industry document archive: new directions in research on corporate political strategy","volume":"114","author":"MacKenzie","year":"2023","journal-title":"Int. J. Drug Pol."},{"key":"10.1016\/j.socscimed.2025.118247_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fcomm.2020.00064","article-title":"Framing science: how opioid research is presented in online news media","volume":"5","author":"Matthias","year":"2020","journal-title":"Front. Commun."},{"issue":"12","key":"10.1016\/j.socscimed.2025.118247_bib31","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1007\/s11606-019-05584-5","article-title":"The \u201cnuts and bolts\u201d of opioid marketing: promotional messages to family doctors in Sacramento, Vancouver, Montreal, and Toulouse","volume":"35","author":"Mintzes","year":"2020","journal-title":"J. Gen. Intern. Med."},{"issue":"1","key":"10.1016\/j.socscimed.2025.118247_bib32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12954-020-00443-7","article-title":"Reporting on the opioid crisis (2000\u20132018): role of the Globe and Mail, a Canadian English-language newspaper in influencing public opinion","volume":"17","author":"Quan","year":"2020","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.socscimed.2025.118247_bib33","author":"Rein"},{"issue":"1","key":"10.1016\/j.socscimed.2025.118247_bib34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF02832235","article-title":"Frame-critical policy analysis and frame-reflective policy practice","volume":"9","author":"Rein","year":"1996","journal-title":"Knowl. Pol."},{"issue":"8","key":"10.1016\/j.socscimed.2025.118247_bib35","first-page":"1550","article-title":"A framing analysis of consultation submissions on the WHO global strategy to reduce the harmful use of alcohol: values and interests","volume":"11","author":"Rinaldi","year":"2021","journal-title":"Int. J. Health Pol. Manag."},{"issue":"2","key":"10.1016\/j.socscimed.2025.118247_bib36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1215\/03616878-8004862","article-title":"Criminal justice or public health: a comparison of the representation of the crack cocaine and opioid epidemics in the media","volume":"45","author":"Shachar","year":"2020","journal-title":"J. Health Polit. Pol. Law"},{"issue":"9","key":"10.1016\/j.socscimed.2025.118247_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040286","article-title":"Ghost management: how much of the medical literature is shaped behind the scenes by the pharmaceutical industry?","volume":"4","author":"Sismondo","year":"2007","journal-title":"PLoS Med."},{"issue":"4","key":"10.1016\/j.socscimed.2025.118247_bib38","doi-asserted-by":"crossref","first-page":"284","DOI":"10.7326\/0003-4819-145-4-200608150-00008","article-title":"Narrative review: the promotion of gabapentin: an analysis of internal industry documents","volume":"145","author":"Steinman","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.socscimed.2025.118247_bib52","series-title":"Policy paradox: the art of political decision making","author":"Stone","year":"1988"},{"key":"10.1016\/j.socscimed.2025.118247_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103749","article-title":"Permissive regulation: a critical review of the regulatory history of buprenorphine formulations in Canada","volume":"105","author":"Sud","year":"2022","journal-title":"Int. J. Drug Pol."},{"key":"10.1016\/j.socscimed.2025.118247_bib40","series-title":"Health Canada Asked 102 Drug Manufacturers and Distributors to Stop Marketing Opioids, 25 Responded","author":"Tunney","year":"2018"},{"issue":"11","key":"10.1016\/j.socscimed.2025.118247_bib41","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1007\/s11606-021-06799-1","article-title":"Learning from the opioid epidemic: preventing the next healthcare marketing crisis","volume":"36","author":"Uppal","year":"2021","journal-title":"J. Gen. Intern. Med."},{"issue":"1","key":"10.1016\/j.socscimed.2025.118247_bib42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/0275074014533142","article-title":"From policy \u201cframes\u201d to \u201cframing\u201d: theorizing a more dynamic, political approach","volume":"46","author":"van Hulst","year":"2016","journal-title":"Am. Rev. Publ. Adm."},{"issue":"2","key":"10.1016\/j.socscimed.2025.118247_bib43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2105\/AJPH.2007.131714","article-title":"The promotion and marketing of OxyContin: commercial triumph, public health tragedy","volume":"99","author":"Van Zee","year":"2009","journal-title":"Am. J. Publ. Health"},{"key":"10.1016\/j.socscimed.2025.118247_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2019.112642","article-title":"A critical content analysis of media reporting on opioids: the social construction of an epidemic","volume":"244","author":"Webster","year":"2020","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.socscimed.2025.118247_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2021.114087","article-title":"Political frames of public health crises: discussing the opioid epidemic in the US Congress","volume":"281","author":"Weiss","year":"2021","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.socscimed.2025.118247_bib46","doi-asserted-by":"crossref","DOI":"10.1215\/03616878-9716712","article-title":"Marketing Opioids to Veterans and Older Adults: A Content Analysis of Internal Industry Documents Released from State of Oklahoma v. Purdue Pharma, L.P. et al","author":"Yakubi","year":"2022","journal-title":"J. Health Polit. Pol. Law"},{"issue":"11","key":"10.1016\/j.socscimed.2025.118247_bib47","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-052636","article-title":"Industry strategies to market opioids to children and women in the USA: A content analysis of internal industry documents from 1999 to 2017 released in State of Oklahoma v. Purdue Pharma, L.P. et al","volume":"12","author":"Yakubi","year":"2022","journal-title":"BMJ Open"}],"container-title":["Social Science & Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0277953625005787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0277953625005787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T09:25:25Z","timestamp":1773393925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0277953625005787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":48,"alternative-id":["S0277953625005787"],"URL":"https:\/\/doi.org\/10.1016\/j.socscimed.2025.118247","relation":{},"ISSN":["0277-9536"],"issn-type":[{"value":"0277-9536","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Framing coalitions and the Canadian overdose crisis: The case of opioid marketing","name":"articletitle","label":"Article Title"},{"value":"Social Science & Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.socscimed.2025.118247","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"118247"}}